- Joined
- Mar 5, 2014
- Messages
- 1,098
- Reaction score
- 102
For Class 1c drugs, FA states that it doesnt increase the APD/ERP in ventricular tissue(ventricular AP), but in the AV node and accessory tracts(im assuming WPW and such) it prolongs the ERP, but it doesnt have the diagram for it, and i did pharm from kaplan and they didnt mention it. So is this an important point, bc FA didnt draw the diagram in.